| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006062097A1 Agent for prevention and/or treatment of pruritus |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006061642A1 Compounds |
| 06/15/2006 | WO2006060871A1 Binding partners of antibodies specific for dendritic cell antigens |
| 06/15/2006 | WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | WO2006032269A3 Pharmaceutical product containing blood constituents and or kda, and the use of the same for the prophylaxis and treatment of defects of the immune system |
| 06/15/2006 | WO2006024367A3 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases |
| 06/15/2006 | WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128728 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 06/15/2006 | US20060128707 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
| 06/15/2006 | US20060128659 Sulfotransferase inhibitors |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127507 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 06/15/2006 | US20060127494 Biologically active products |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127357 Rapamycin and il-10 for the treatment of immune diseases |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/15/2006 | CA2590180A1 Binding partners of antibodies specific for dendritic cell antigens |
| 06/14/2006 | EP1669450A1 Staple type oligonucleotide and drug comprising the same |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
| 06/14/2006 | EP1668142A1 Modified vaccinia virus ankara (mva) mutant and use thereof |
| 06/14/2006 | EP1668036A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 06/14/2006 | EP1667971A1 Fexofenadine polymorphs and processes of preparing the same |
| 06/14/2006 | EP1667718A2 Method of promoting graft survival with anti-tissue factor antibodies |
| 06/14/2006 | EP1667707A1 Methods of stimulating innate immunity using cationic peptides |
| 06/14/2006 | EP1667706A1 G-csf derivative for inducing immunological tolerance |
| 06/14/2006 | EP1667678A1 Animal feed composition |
| 06/14/2006 | EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1349550B1 Substituted-4-quinolones for the treatment of autoimmune diseases |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1278825B1 Methods of producing membrane vesicles |
| 06/14/2006 | EP1278429B1 Process for enhancing immune response in canines using a dietary composition including garlic |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1102596B1 Peptide antagonists of zonulin and methods for use of the same |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1003551B1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | CN1788007A Crystal of benzimidazole derivative and process for producing the same |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1787836A Avian combination-vaccine against e.coli and salmonella |
| 06/14/2006 | CN1786167A Polypeptide of anti HIV virus and its coding gene and application |
| 06/14/2006 | CN1785319A Chinese medicinal composition for antifatigue and increasing immune power and its preparation method |
| 06/14/2006 | CN1785285A Extraction method of hawthorn lenf |
| 06/14/2006 | CN1785227A Extractive of Hema-ethyl acetate and its action |
| 06/14/2006 | CN1785204A Baicalin freeze-drying powder for injection use and its prepn. method |
| 06/14/2006 | CN1785183A Injection used for improving immunity of human |
| 06/14/2006 | CN1785178A Novel use of effective constituent Nodosin of rabdosia lophanthide |
| 06/14/2006 | CN1785176A Soft capsule of mycophenolic acid or like and its prepn. method |
| 06/14/2006 | CN1785055A Health-care food with function for improving immunity and its prepn. method |
| 06/14/2006 | CN1785046A Health-care food Lingchong crusta-amine for improving user's immunity and its prepn. method |
| 06/14/2006 | CN1785031A Ice-cream contg. immune globulin-G biological factor |
| 06/14/2006 | CN1259340C Peptide composition as immunogen for treatment of allergy |